MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 206 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $296,000 | -10.3% | 11,594 | 0.0% | 0.08% | -7.2% |
| Q2 2022 | $330,000 | -19.3% | 11,594 | 0.0% | 0.08% | -5.7% |
| Q1 2022 | $409,000 | -15.8% | 11,594 | 0.0% | 0.09% | -9.3% |
| Q4 2021 | $486,000 | -14.6% | 11,594 | 0.0% | 0.10% | -22.4% |
| Q3 2021 | $569,000 | +17.8% | 11,594 | 0.0% | 0.12% | +9.6% |
| Q2 2021 | $483,000 | – | 11,594 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $615,958,000 | 21.97% |
| Nekton Capital Ltd. | 896,469 | $25,469,000 | 8.21% |
| Pavadi Capital LLC | 158,520 | $4,504,000 | 4.08% |
| Curi Wealth Management, LLC | 430,451 | $12,229,000 | 2.35% |
| Ownership Capital B.V. | 4,392,050 | $124,778,000 | 2.14% |
| Select Equity Group, L.P. | 19,114,926 | $543,055,000 | 1.74% |
| MOODY ALDRICH PARTNERS LLC | 285,091 | $8,099,000 | 1.59% |
| Beck Bode, LLC | 178,916 | $5,083,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 24,500 | $696,000 | 0.97% |
| Eversept Partners, LP | 425,364 | $12,084,591 | 0.86% |